Terms: = Pancreatic cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310 AND Prognosis
2 results:
1. E3 ubiquitin ligase ubr5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract] [Full Text] [Related]
2. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.
Jadid MFS; Shademan B; Chavoshi R; Seyyedsani N; Aghaei E; Taheri E; Goleij P; Hajazimian S; Karamad V; Behroozi J; Sabet MN; Isazadeh A; Baradaran B
Environ Toxicol; 2021 Jun; 36(6):1043-1051. PubMed ID: 33496383
[TBL] [Abstract] [Full Text] [Related]
